The CGC represents clinical cytogeneticists, molecular geneticists, and molecular pathologists to promote best practices & education in clinical cancer genomics
United States
Joined August 2016
- Tweets2.5K
- Following2.8K
- Followers2.1K
- Likes1.2K
The CGC Early Career Webinar is almost here!
Join the CGC Early Career Committee for The Negotiation Gene: Do You Have It?
Featuring Kelly Quesnelle, PhD, FAAPE, and Avni B. Santani, PhD, FACMG
📅 October 28 | 10:00 AM PDT / 12:00 PM CDT / 1:00 PM EDT
🌟 CGC Volunteer Spotlight: Fang Fang, PhD!
Fang is a CGC Trainee Member, Assistant Laboratory Director at Natera, and a volunteer with the CCGA Working Group. We’re grateful for her contributions to the CGC community! 🧬
#CGC #CancerGenomics
Tomorrow! Join Dr. David Scott as we dive into the evolving science of aggressive B-cell lymphoma. Explore molecular classifications and how they are advancing our understanding of the disease.
🗓️ October 13 | 12–1 p.m. ET
Join the discussion: buff.ly/gw4QM8f
Coming up Tuesday!
Join CGC on October 13 for a scientific discussion with Dr. David Scott on molecular classifications of aggressive B-cell lymphoma and their implications for understanding the disease.
🗓️ Tuesday, October 13
⏰ 12–1 p.m. ET
A year of growth. A vision for 2027.
Explore CGC’s 2026 highlights and priorities for the year ahead in a letter from President Cate Randal Paschal, PhD, FACMG.
👉 buff.ly/CfXT0lI
#CancerGenomics #CGC
🧬 Have an idea for CGC 2027?
Invited Session Proposals are now open for the 18th Annual Meeting in Seattle!
Submit ideas for scientific talks, panels, or interactive workshops.
📅 Deadline: November 16, 2026
Learn more and submit your proposal: buff.ly/CBfvBY6
📚 New CGC publication!
The Somatic Overgrowth & Vascular Anomalies Working Group published a review in Genetics in Medicine on genetic testing and mosaic variants.
🔗 Read the full article: buff.ly/jjbKBcq
Q46: An 83-year-old man with DLBCL and a hx of prostate cancer has a TP53 path variant (VAF 45%) in blood. Family hx is negative. What’s the next step?
A. Report + familial testing
B. Report; likely de novo
C. Test another tissue for mosaicism
D. Test another tissue; likely CHIP
The CGC Early Career Initiative has had a busy year of webinars, mentoring, networking, and outreach for early-career professionals.
Next up: 🧬 The Negotiation Gene: Do You Have It?
📅 Oct. 28, 2026
Register today 👉️ buff.ly/loo7fQj
Registration is open!
The Negotiation Gene: Do You Have It?
Learn practical strategies for negotiating salary, roles, resources, responsibilities, and career opportunities with confidence.
Featuring Kelly Quesnelle, PhD, FAAPE, & Avni B. Santani, PhD
📅 Oct. 28, 2026
Q46: An 83-year-old man with DLBCL and a hx of prostate cancer has a TP53 path variant (VAF 45%) in blood. Family hx is negative.What’s the next step?
A. Report + familial testing
B. Report; likely de novo
C. Test another tissue for mosaicism
D. Test another tissue; likely CHIP
Webinar reminder: Join us Oct. 13, 12–1 p.m. ET, for a scientific discussion on molecular classifications of aggressive B-cell lymphoma with David Scott, MD, PhD.
Register: buff.ly/gw4QM8f
Join us Oct. 13, 12–1 p.m. ET, for a scientific discussion on molecular classifications of aggressive B-cell lymphoma with David Scott, MD, PhD.
🧬 Register today: buff.ly/gw4QM8f
